(Albany, USA) DelveInsight’s “Thyroid Eye Disease Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the Thyroid Eye Disease, historical and forecasted epidemiology as well as the Thyroid Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Thyroid Eye Disease market key facts
- According to Jolene et al. (2020), the overall pooled prevalence of TED was 38% (CI: 0.31 to 0.46) for Europe, 44% (CI: 0.32 to 0.56) for Asia, 27% (CI: 0.06 to 0.56) for North America and 58% (CI: 0.55 to 0.61) for Oceania and in Southeast Asia was 35% (CI: 0.24 to 0.47).
- A higher prevalence of Thyroid Eye Disease has been observed in women as compared to men (16 per 100,000 vs. 3 per 100,000, respectively).
- Both men and women demonstrate a bimodal pattern of age of diagnosis for Thyroid Eye Disease (i.e 40–44 and 60–64 years in women; 45–49 and 65–69 years in men).
- According to a review article titled “Epidemiology and Prevention of Graves’ Ophthalmopathy” by Wilmar et al., Graves’ ophthalmopathy is clinically relevant in approximately 50% of patients with Graves’ disease, and severe forms affect less than 5% of patients.
Request for a sample to know more about the Thyroid Eye Disease market report offerings @ Thyroid Eye Disease Market Insight
Key benefits of Thyroid Eye Disease Market report
- The Thyroid Eye Disease market report provides an in-depth analysis of the Thyroid Eye Disease market, size, share, trend analysis epidemiology, and market forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
- The Thyroid Eye Disease market report covers Thyroid Eye Disease current treatment practices, emerging drugs, and market share of individual therapies.
- The Thyroid Eye Disease market report covers the marketed and emerging therapies for Thyroid Eye Disease.
- The Thyroid Eye Disease market report helps businesses understand the Thyroid Eye Disease market trends that will shape and drive the Thyroid Eye Disease market in upcoming years.
To know more about Thyroid Eye Disease market drivers and barriers, click here @ Thyroid Eye Disease Market Dynamics
Thyroid Eye Disease Market
The Thyroid Eye Disease market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Thyroid Eye Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
The Thyroid Eye Disease market segment gives a thorough detail of the Thyroid Eye Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The rise in the number of patients with thyroid disorders, favorable reimbursement policies for treatment, and an increase in awareness about the complications associated with thyroid disorders are the major drivers of the Graves disease market. Increasing iodine disorder and thyroid tumor screening are one of the leading factors fueling the growth of the market.
The launch of the emerging therapies is expected to significantly impact the Thyroid Eye Disease treatment scenario in the upcoming years. Some of the drugs covered in the report include VRDN—001 (Viridian Therapeutics), Secukinumab (Novartis), and IMVT-1401 (Immunovant Sciences GmbH) among others.
Download the sample report to know more about the Thyroid Eye Disease Market trends, pipeline and epidemiology, click here @ Thyroid Eye Disease Market Outlook
Thyroid Eye Disease Companies
- Viridian Therapeutics
- Immunovant Sciences GmbH
- Horizon Therapeutics
- And Several Others
Thyroid Eye Disease Drugs
- Tepezza (teprotumumab)
- And Several Others
Click here to know more about the Thyroid Eye Disease Therapeutic assessment @ Thyroid Eye Disease drugs in pipeline
Table of contents
1. Key Insights
2. Executive Summary of Thyroid Eye Disease
3. Thyroid Eye Disease Competitive Intelligence Analysis
4. Thyroid Eye Disease Market Overview at a Glance
5. Thyroid Eye Disease Disease Background and Overview
6. Thyroid Eye Disease Patient Journey
7. Thyroid Eye Disease Epidemiology and Patient Population
8. Thyroid Eye Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Thyroid Eye Disease Unmet Needs
10. Key Endpoints of Thyroid Eye Disease Treatment
11. Thyroid Eye Disease Marketed Products
12. Thyroid Eye Disease Emerging Therapies
13. Thyroid Eye Disease Seven Major Market Analysis
14. Attribute analysis
15. Thyroid Eye Disease Market Outlook (in 7 major markets)
16. Access and Reimbursement Overview of Thyroid Eye Disease
17. KOL Views on the Thyroid Eye Disease market.
18. Thyroid Eye Disease Market Drivers
19. Thyroid Eye Disease Market Barriers
21. DelveInsight Capabilities
Acute Radiation Syndrome Market
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States